Skip to content

Can Osteoboost be used for osteoporosis?

4 min read

In May 2025, the U.S. Food and Drug Administration (FDA) cleared Osteoboost as the first non-drug prescription treatment for low bone density. This groundbreaking wearable device uses vibration therapy to slow bone loss in the hips and spine, and while it was specifically cleared for postmenopausal women with osteopenia, it raises the important question: can Osteoboost be used for osteoporosis?.

Quick Summary

Osteoboost is an FDA-cleared wearable medical device for postmenopausal women with osteopenia, not osteoporosis, that uses targeted vibration to slow bone loss. Research confirms its efficacy for low bone mass, but its approval status differs from pharmacological treatments for advanced osteoporosis.

Key Points

  • FDA Clearance for Osteopenia: Osteoboost is a prescription medical device cleared by the FDA for postmenopausal women with osteopenia, not for treating established osteoporosis.

  • Mechanism of Action: The device is a wearable belt that delivers targeted, high-frequency vibrations to the hips and spine to stimulate bone formation and slow bone loss.

  • Not a Drug: Unlike traditional osteoporosis treatments, Osteoboost is a non-pharmacological therapy with no reported serious side effects, giving it high patient adherence.

  • Complementary to Lifestyle: For best results, Osteoboost should be used in conjunction with a bone-healthy diet and weight-bearing exercise.

  • Filling a Treatment Gap: Osteoboost addresses the unmet need for effective, safe, early-stage intervention in postmenopausal women with low bone density before the condition becomes severe osteoporosis.

In This Article

What is Osteoboost and how does it work?

Osteoboost is a prescription-only, non-pharmacological medical device developed by Bone Health Technologies (BHT). It is a belt-like wearable that delivers calibrated, high-frequency vibrations directly to the lumbar spine and hips—areas highly susceptible to bone loss. The mechanism is based on decades of biomechanics research, including NASA-funded studies, showing that targeted mechanical stimulation can reduce bone loss. By stimulating the bones, the vibrations mimic the natural mechanical forces that signal bone cells to increase density and strength.

Unlike oral medications or injections, Osteoboost has no systemic side effects and boasts high patient adherence. Users wear the device for a recommended 30 minutes per day while performing daily activities like walking or cooking. The ease of use, coupled with strong clinical trial results demonstrating significant reductions in bone density and strength loss, marks a significant advancement in preventative bone health.

Can Osteoboost be used for osteoporosis? The difference between Osteopenia and Osteoporosis

To understand why Osteoboost is not cleared for osteoporosis, it is crucial to recognize the difference between osteopenia and osteoporosis. Osteopenia is a condition where bone density is lower than normal but not yet severe enough to be classified as osteoporosis. Think of it as a precursor to osteoporosis. Osteoporosis, meaning "porous bones," is a more severe, progressive condition where bone tissue has deteriorated significantly, leading to a much higher risk of fractures.

Osteoboost received FDA clearance specifically for postmenopausal women diagnosed with osteopenia. The clinical trials demonstrated its effectiveness in slowing bone loss during this earlier, less severe stage. Because it is designed to preserve existing bone density rather than rebuild severely compromised bone, its approved use is for prevention and early intervention, not the treatment of advanced osteoporosis. The company has expressed interest in pursuing broader applications, including for osteoporosis, but that requires further research and regulatory approval.

Comparing Osteoboost with traditional osteoporosis treatments

Traditional osteoporosis treatments are typically drug-based and fall into two main categories: antiresorptive medications and osteoanabolic medications. Osteoboost, as a non-pharmacological device, represents a new class of therapy entirely.

Feature Osteoboost (Vibration Therapy) Traditional Osteoporosis Medications
Treatment Type Wearable medical device (vibration) Oral tablets, injections, or infusions (drugs)
Mechanism Stimulates bone formation with mechanical vibration Inhibits bone breakdown or promotes new bone growth with drugs
Approved For Postmenopausal women with osteopenia Individuals with osteoporosis, often those at high risk of fracture
Approval Status FDA-cleared as a prescription device FDA-approved pharmaceuticals
Safety & Side Effects Excellent safety profile; no serious adverse events reported Potential side effects including gastrointestinal issues, flu-like symptoms, or rare severe complications
Compliance High compliance rates in clinical trials due to ease of use Varies depending on medication type, dosage, and side effects
Use Case Proactive, early intervention for low bone density Primarily reactive, for moderate to severe osteoporosis

The importance of lifestyle interventions alongside medical treatment

While medical devices like Osteoboost and pharmaceutical options can be highly effective, they are most successful when used in combination with healthy lifestyle habits. For individuals with osteopenia or osteoporosis, a multi-faceted approach is critical. This includes:

  • Diet: A balanced diet rich in calcium and vitamin D is essential for bone health. Good sources include dairy products, leafy greens, fortified foods, and fatty fish. Magnesium, zinc, and vitamin K also play crucial roles.
  • Exercise: Weight-bearing exercises like brisk walking, jogging, and strength training help strengthen bones and muscles. Balance exercises, such as Tai Chi, are also beneficial for reducing fall risk.
  • Supplements: When dietary intake is insufficient, supplements for calcium and vitamin D may be recommended by a healthcare provider.
  • Avoidance of Harmful Habits: Excessive alcohol consumption and tobacco use have detrimental effects on bone health and should be avoided.

Conclusion

In conclusion, while Osteoboost represents a significant and safe advancement in the treatment of low bone density, it is not a cure for established osteoporosis and is not FDA-cleared for this purpose. The wearable device is specifically prescribed for postmenopausal women with osteopenia to help slow the progression of bone loss. Its emergence highlights a new paradigm in bone health: proactive, non-drug intervention for patients in the earlier stages of bone mineral loss. Patients with osteoporosis should consult their doctor to discuss FDA-approved pharmacological options that are proven to be effective for their condition. It is also important for individuals to maintain a healthy lifestyle, including proper diet and exercise, to support their overall bone health, regardless of their diagnosis.

Medical News Today offers additional insights on supplements that can support bone health and may be relevant for individuals with bone density concerns.

Frequently Asked Questions

No, Osteoboost is not a medication. It is a prescription-only, wearable medical device that uses targeted vibration therapy to stimulate bone formation.

Osteoboost is approved for use in postmenopausal women who have been diagnosed with osteopenia, a condition characterized by lower-than-normal bone density.

No, Osteoboost is a prescription-only device. You must consult with your doctor to see if it is the right treatment option for you.

Yes, clinical trials have shown Osteoboost to have an excellent safety profile with no serious adverse events reported.

The manufacturer recommends using the Osteoboost device for 30 minutes per day. Clinical trial participants who used it at least three times per week saw significant benefits.

No, Osteoboost is not a replacement for exercise. It is meant to be used alongside a healthy routine that includes diet and exercise to support bone health.

The main difference is their approach and approval. Osteoboost is a non-drug device for early intervention in osteopenia, while traditional drugs are systemic medications for treating more advanced osteoporosis.

References

  1. 1
  2. 2
  3. 3
  4. 4

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.